everything.study
HST.590

Biomedical Engineering Seminar Series

1-0-0 units · Graduate

Seminars focused on the development of professional skills for biomedical engineers and scientists. Each term focuses on a different topic, resulting in a repeating cycle that covers biomedical and research ethics, business and entrepreneurship, global health and biomedical innovation, and health systems and policy. Includes guest lectures, case studies, interactive small group discussions, and role-playing simulations.

Fall 2006 · Biomedical Engineering Seminar Series: Developing Professional Skills

This course consists of a series of seminars focused on the development of professional skills. Each semester focuses on a different topic, resulting in a repeating cycle that covers medical ethics, responsible conduct of research, written and oral technical communication, and translational issues. Material and activities include guest lectures, case studies, interactive small group discussions, and role-playing simulations.

Fall 2005 · Biomedical Engineering Seminar Series: Topics in Medical Ethics and Responsible Conduct in Research

Topics

  • The Ethics of Genetic Screening for Therapeutic Procedures

Readings

  • Drazen, Jeffrey M., and Gregory D. Curfman. “On Authors and Contributors.” N Engl J Mcd 347 (2002): 55.
    Listed reading
  • Kempers, R. D. “Ethical issues in biomedical publications.” Fertil Steril 77 (2002): 883-888.
    Listed reading
  • Hashimoto, H., et al. “The diffusion of medical technology, local conditions, and technology re-invention: A comparative case study on coronary stenting.” Health Policy (February 10, 2006). [e-pub ahead of print.]
    Listed reading
  • Libeer, J. C. “Role of external quality assurance schemes in assessing and improving quality in medical laboratories.” Clin Chim Acta 309 (2001): 173-177.
    Listed reading
  • Chadwick, R., and U. Schuklenk. “Sleeping with the enemy? Where to draw the line on research funding?” Bioethics 19 (2005): iii-iv.
    Listed reading
  • Cichy, K. A. “Ethical implications of for-profit corporate sponsorship of research.” SRA J 22 (1990): 23-27.
    Listed reading
  • Gericke, C. A., A. Riesberg, and R. Busse. “Ethical issues in funding orphan drug research and development.” J Med Ethics 31 (2005): 164-168.
    Listed reading
  • Hughes, D. A., B. Tunnage., and S. T. Yeo. “Drugs for exceptionally rare diseases: do they deserve special status for funding?” QJM 98 (2005): 829-836.
    Listed reading

Prerequisites & course information

Prereq: None G (Fall, Spring) 1-0-0 units Can be repeated for credit.

Sources